-
HIV Drugs Market Size Is Set to Grow by USD 10.47 Billion From 2023-2027
23 Apr 2024 16:49 GMT
… pharmaceutical products designed to manage and treat HIV infections. Key HIV drugs include Atripla, Complera … crucial for effective treatment with HIV medications.
Key Market Drivers
The HIV drugs market is …
-
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
26 Mar 2024 12:00 GMT
… room TVs in doctor offices, and … Food and Drug Administration (FDA)-approved treatment of its … medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY, CABENUVA) used to treat HIV … Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a …
-
B.C. class action suit approved against HIV/AIDs drugmaker Gilead
26 Mar 2024 06:03 GMT
… a pharmaceutical company that develops drugs to treat HIV/AIDS.
A … drugs in Canada under the brands Viread, Truvada, Atripla, Complera … their families.
The trial will try to determine … , wellness, healthy living, drugs, treatments and more, head to …
-
HIV Drugs Market Size to Surpass with a Growing CAGR of 3.7% by 2030, Trends, Growth Strategies and Competitive Analysis
06 Feb 2024 09:16 GMT
…
• Janssen Pharmaceuticals Inc. ( … HIV Drugs is a major barrier to treatment. The generic HIV Drugs … HIV medicines segment can be further classified into Atripla, Complera … HIV research and development organizations, such as the International AIDS Vaccine …
-
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults
01 Nov 2023 21:00 GMT
… commercializing novel treatments for gastrointestinal … Food and Drug Administration (FDA) has … medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY, CABENUVA) used to treat HIV … Pharmaceuticals at 1-888- 775-PHAT (7428) or FDA at 1-800-FDA …
-
Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for VOQUEZNA® TRIPLE PAK® (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA® DUAL PAK® (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
30 Oct 2023 12:00 GMT
… -packaged prescription medicines for the treatment of a … are taking:
medicines that contain rilpivirine (Edurant, Complera, Odefsey) … (hypersensitivity): Call your doctor right away if you … Pharmaceuticals at 1-888- 775-PHAT (7428) or FDA at 1-800-FDA …
-
GILD, BIIB, and KRTX: Biotech Buy, Hold, or Sell?
09 Dec 2023 02:26 GMT
… applications of biotechnology, especially in the medical field. The … need for quality treatments, a robust drug pipeline, supportive … , Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, … the acquisition of Reata Pharmaceuticals, gaining access to …
-
Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
28 Nov 2023 13:00 GMT
… treatment option.” The U.S. Food and Drug Administration (FDA … medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY, CABENUVA) used to treat HIV … ): Call your doctor right away if … Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a …
-
3 Biotech Stocks to Buy This Month and Beyond
25 Aug 2023 18:44 GMT
… medical care and treatment.
In light of this, fundamentally sound biotech … includes Odefsey, Biktarvy, Truvada, Complera/ Eviplera, Stribild, … S. Food and Drug Administration (FDA) approved a … with the pan-Canadian Pharmaceutical Alliance (pCPA) for Rylaze …
-
3 Biotech Stocks With Some Major Value in Them
27 Jun 2023 20:59 GMT
… , the global biotechnology market is estimated … HIV), viral hepatitis, and cancer. Its product portfolio includes Odefsey, Truvada, Complera … to enhance the treatment experience for patients … pharmaceutical products to address patients’ unmet medical needs …